{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:36:19Z","timestamp":1791246979241,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08 122306"],"award-info":[{"award-number":["K08 122306"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32 HL715041"],"award-info":[{"award-number":["T32 HL715041"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005620","name":"North Carolina GlaxoSmithKline Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","award":["TCR2"],"award-info":[{"award-number":["TCR2"]}],"id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bbmt.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T06:18:28Z","timestamp":1539065908000},"page":"549-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["CD3+\/CD19+ Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic Disorders"],"prefix":"10.1016","volume":"25","author":[{"given":"Joseph H.","family":"Oved","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios S.","family":"Monos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan A.","family":"Grupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Bunin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2018.10.003_bib0001","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MOH.0b013e328365af83","article-title":"Haematopoietic stem cell transplantation for acquired aplastic anaemia","volume":"20","author":"Young","year":"2013","journal-title":"Curt Opin Hematol"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0002","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/bjh.12787","article-title":"Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry","volume":"165","author":"Fagioli","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0003","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2010-09-306829","article-title":"HLA-matched sibling bone marrow transplantation for B-thalassemia major","volume":"117","author":"Sabioff","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0004","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/ajh.24183","article-title":"Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies","volume":"90","author":"King","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0005","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0006","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2010-02-251090","article-title":"How I treat Diamond-Blackfan anemia","volume":"116","author":"Viachos","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0007","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on GCSF therapy","volume":"150","author":"Rosenberg","year":"2010","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.bbmt.2018.10.003_bib0008","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.blre.2018.02.001","article-title":"A paradigm shift on beta-thalassemia treatment: how will we manage this old disease with new therapies?","volume":"32","author":"Cappellini","year":"2018","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0009","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.13614","article-title":"Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anemia","volume":"171","author":"Dufour","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0010","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbmt.2016.12.628","article-title":"Alternative donor transplantation with high dose post-transplantation cyclophosphamide for refractory severe aplastic anemia","volume":"23","author":"DeZern","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0011","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbmt.2018.01.023","article-title":"Unrelated donor transplantation in children with thalassemia using reduced-intensity conditioning: The URTH Trial","volume":"24","author":"Shenoy","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0012","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1182\/blood-2016-05-715870","article-title":"A trial of unrelated donor marrow transplantation for children with severe sickle cell disease","volume":"128","author":"Shenoy","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0013","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2016-09-743112","article-title":"Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study","volume":"129","author":"Mehta","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbmt.2018.10.003_bib0014","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2174\/1574888X12666170227151226","article-title":"Allogeneic hematopoietic stem cell transplant for severe aplastic anemia: current state and future directions","volume":"13","author":"Sun","year":"2018","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0015","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.bbmt.2017.12.674","article-title":"Abatacept for GVHD prophylaxis after hematopoietic stem cell transplantation (HCT) for pediatric sickle cell disease (SCD): A sickle transplant alliance for research (STAR) trial","volume":"24","author":"Chaudhury","year":"2018","journal-title":"Biol Blood Marrow Transplantat"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0016","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.bbmt.2015.06.005","article-title":"Use of Alefacept for preconditioning in multiply transfused pediatric patients with nonmalignant diseases","volume":"21","author":"Stenger","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0017","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bbmt.2013.08.003","article-title":"Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood","volume":"19","author":"Oshrine","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0018","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.bmt.1704803","article-title":"Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion","volume":"35","author":"Bunin","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0019","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bmt.1704754","article-title":"Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias","volume":"35","author":"Bunin","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/08880018.2016.1204399","article-title":"Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell depleted grafts from human leukocyte antigen-matched or-mismatched donors","volume":"33","author":"Mussetti","year":"2016","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bjh.12400","article-title":"The current role of T cell depletion in paediatric stem cell transplantation","volume":"162","author":"Booth","year":"2013","journal-title":"Br J Harmatol"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0022","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0023","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jama.2015.13706","article-title":"Global use of peripheral blood vs bone marrow as source of stem cells for allogeneic transplantation in patients with bone marrow failure","volume":"315","author":"Yoshimi","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0024","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2011-05-354001","article-title":"Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia","volume":"118","author":"Eapen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0025","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbmt.2009.07.009","article-title":"Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation","volume":"15","author":"Pidala","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0026","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.bbmt.2015.11.356","article-title":"Favorable chronic graft-versus-host-disease (GVHD), event-free (EFS), and overall survival (OS) rates following partially CD3-depleted alternative donor peripheral stem cell transplantation (PSCT) for pediatric hematologic malignancies","volume":"22","author":"Seif","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/bloodadvances.2017012682","article-title":"Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype","volume":"2","author":"Sarthy","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0028","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12185-011-0931-7","article-title":"Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria","volume":"94","author":"Taniguchi","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0029","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbmt.2012.04.014","article-title":"Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life threatening adverse events at predefined cyclophosphamide dose levels","volume":"18","author":"Tolar","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-vesus-host disease clinical data collection: a report from the MAGIC consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0031","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S2352-3026(15)00147-7","article-title":"Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalatation study","volume":"2","author":"Anderlini","year":"2015","journal-title":"Lancet Hematol"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0032","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0033","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/bmt.2015.20","article-title":"Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study","volume":"50","author":"Esteves","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0034","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene therapy in patients with transfusion-dependent \u03b2-thalassemia","volume":"378","author":"Thompson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0035","article-title":"Molecular approaches to diagnose Diamond-Blackfan anemia: the EuroDBA experience","author":"Da Costa","year":"2017","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.bbmt.2018.10.003_bib0036","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of Children with acute leukemia given HLA-haploidentical HSCT after \u03b1\u03b2 T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118306128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118306128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:07:15Z","timestamp":1761059235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118306128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1083879118306128"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.10.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD3+\/CD19+ Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic Disorders","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}